Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease

References

• Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572–20. doi:10.1053/j.gastro.2011.09.002.
   PubMed Web of Science ®Google Scholar
• Xu H, Wang H. Immune cells in alcohol-related liver disease. Liver Research. 2022;6(1):1–9. doi:10.1016/j.livres.2022.01.001.
   Google Scholar
• Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S. Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2011;300(4):G516–25. doi:10.1152/ajpgi.00537.2010.
   PubMed Web of Science ®Google Scholar
• Szabo G, Thursz M, Shah VH. Therapeutic advances in alcohol-associated hepatitis. J Hepatol. 2022;76(6):1279–1290. doi:10.1016/j.jhep.2022.03.025.
   PubMed Web of Science ®Google Scholar
• Wang H, Mehal W, Nagy LE, Rotman Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol. 2021;18(1):73–91. doi:10.1038/s41423-020-00579-3.
   PubMed Web of Science ®Google Scholar
• Gao B, Ahmad MF, Nagy LE, Tsukamoto H. Inflammatory pathways in alcoholic steatohepatitis. J Hepatol. 2019;70(2):249–259. doi:10.1016/j.jhep.2018.10.023.
   PubMed Web of Science ®Google Scholar
• Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology. 2006;43(Supplement 1):S54–S62. doi:10.1002/hep.21060.
   PubMedGoogle Scholar
• Mikulak J, Bruni E, Oriolo F, Di Vito C, Mavilio D. Hepatic natural killer cells: organ-specific sentinels of liver immune homeostasis and physiopathology. Front Immunol. 2019;10:946. doi:10.3389/fimmu.2019.00946.
   PubMed Web of Science ®Google Scholar
• Tian P, Yang W, Guo X, Wang T, Tan S, Sun R, Xiao R, Wang Y, Jiao D, Xu Y, et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis. Nat Commun. 2023;14(1):1710. doi:10.1038/s41467-023-37419-7.
   PubMed Web of Science ®Google Scholar
• Chaudhry S, Emond J, Griesemer A. Immune cell trafficking to the liver. Transplantation. 2019;103(7):1323–1337. doi:10.1097/TP.0000000000002690.
   PubMed Web of Science ®Google Scholar
• Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231–242. doi:10.1038/nrgastro.2015.35.
   PubMed Web of Science ®Google Scholar
• Gao B, Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta. 2013;1832(7):1061–1069. doi:10.1016/j.bbadis.2012.09.008.
   PubMed Web of Science ®Google Scholar
• Wu D, Li Y. Application of adoptive cell therapy in hepatocellular carcinoma. Immunology. 2023;170(4):453–469. doi:10.1111/imm.13677.
   PubMed Web of Science ®Google Scholar
• Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology. 2008;47(2):729–736. doi:10.1002/hep.22034.
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology. 2006;44(6):1441–1451. doi:10.1002/hep.21419.
   PubMed Web of Science ®Google Scholar
• Tacke F, Puengel T, Loomba R, Friedman SL. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J Hepatol. 2023;79(2):552–566. doi:10.1016/j.jhep.2023.03.038.
   PubMed Web of Science ®Google Scholar
• Pan HN, Sun R, Jaruga B, Hong F, Kim WH, Gao B. Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis. Alcohol Clin Exp Res. 2006;30(9):1615–1623. doi:10.1111/j.1530-0277.2006.00194.x.
   PubMed Web of Science ®Google Scholar
• Chen P, Starkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology. 2015;61(3):883–894. doi:10.1002/hep.27489.
   PubMed Web of Science ®Google Scholar
• Ryu T, Kim K, Choi SE, Chung KPS, Jeong W-I. New insights in the pathogenesis of alcohol-related liver disease: the metabolic, immunologic, and neurologic pathways☆. Liver Research. 2023;7(1):1–8. doi:10.1016/j.livres.2022.09.004.
   Google Scholar
• Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009;43(2):163–172. doi:10.1016/j.alcohol.2008.12.009.
   PubMed Web of Science ®Google Scholar
• Lee NY, Yoon SJ, Han DH, Gupta H, Youn GS, Shin MJ, Ham YL, Kwak MJ, Kim BY, Yu JS, et al. Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes. 2020;11(4):882–899. doi:10.1080/19490976.2020.1712984.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, Hoshi N, Hatano N, Ozawa G, Sasaki N, et al. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation. 2018;138(22):2486–2498. doi:10.1161/CIRCULATIONAHA.118.033714.
   PubMed Web of Science ®Google Scholar
• Song L, Huang Y, Liu G, Li X, Xiao Y, Liu C, Zhang Y, Li J, Xu J, Lu S, et al. A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice. Front Immunol. 2021;12:828887. doi:10.3389/fimmu.2021.828887.
   PubMed Web of Science ®Google Scholar
• Wang Q, Lv L, Jiang H, Wang K, Yan R, Li Y, Ye J, Wu J, Wang Q, Bian X, et al. Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. Appl Microbiol Biotechnol. 2019;103(23–24):9673–9686. doi:10.1007/s00253-019-10211-8.
   PubMed Web of Science ®Google Scholar
• Taverniti V, Guglielmetti S. Health-promoting properties of Lactobacillus helveticus. Front Microbiol. 2012;3:392. doi:10.3389/fmicb.2012.00392.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821.
   PubMed Web of Science ®Google Scholar
• Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The Firmicutes/Bacteroidetes ratio: a relevant Marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5):12. doi:10.3390/nu12051474.
   Web of Science ®Google Scholar
• Bala S, Marcos M, Gattu A, Catalano D, Szabo G, Feng W. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PloS One. 2014;9(5):e96864. doi:10.1371/journal.pone.0096864.
   PubMed Web of Science ®Google Scholar
• Fang H, Liu A, Chen X, Cheng W, Dirsch O, Dahmen U. The severity of LPS induced inflammatory injury is negatively associated with the functional liver mass after LPS injection in rat model. J Inflamm. 2018;15(1):1–9. doi:10.1186/s12950-018-0197-4.
   Google Scholar
• Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol. 2016;8(32):1354–1369. doi:10.4254/wjh.v8.i32.1354.
   PubMedGoogle Scholar
• Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, Luo X, Badea SR, Xu C, Fu G, et al. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12(1):2537. doi:10.1038/s41467-021-22755-3.
   PubMed Web of Science ®Google Scholar
• Choi YH, Lim EJ, Kim SW, Moon YW, Park KS, An H-J. IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells. J Immunother Cancer. 2019;7(1):1–12. doi:10.1186/s40425-019-0652-7.
   PubMed Web of Science ®Google Scholar
• Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol. 2009;50(6):1258–1266. doi:10.1016/j.jhep.2009.03.007.
   PubMed Web of Science ®Google Scholar
• Goikoetxea-Usandizaga N, Bravo M, Egia-Mendikute L, Abecia L, Serrano-Maciá M, Urdinguio RG, Clos-García M, Rodríguez-Agudo R, Araujo-Legido R, López-Bermudo L, et al. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent. Hepatol. 2023;78(3):878–895. doi:10.1097/HEP.0000000000000303.
   PubMed Web of Science ®Google Scholar
• Crome SQ, Lang PA, Lang KS, Ohashi PS. Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013;34(7):342–349. doi:10.1016/j.it.2013.03.002.
   PubMed Web of Science ®Google Scholar
• Luevano M, Madrigal A, Saudemont A. Transcription factors involved in the regulation of natural killer cell development and function: an update. Front Immunol. 2012;3:319. doi:10.3389/fimmu.2012.00319.
   PubMed Web of Science ®Google Scholar
• Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, Colucci F, Buer J, Grosveld F, Godin I, Di Santo JP, et al. GATA-3 promotes maturation, IFN-γ production, and liver-specific homing of NK cells. Immunity. 2003;19(5):701–711. doi:10.1016/S1074-7613(03)00294-2.
   PubMed Web of Science ®Google Scholar
• Lu Y-C, Yeh W-C, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145–151. doi:10.1016/j.cyto.2008.01.006.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhan F, Wang Y, Wang D, Lu H, Wu C, Xia Y, Meng L, Zhang F, Wang X, et al. The Ninj1/Dusp1 axis contributes to liver ischemia reperfusion injury by regulating macrophage activation and neutrophil infiltration. Cell Mol Gastroenterol Hepatol. 2023;15(5):1071–1084. doi:10.1016/j.jcmgh.2023.01.008.
   PubMed Web of Science ®Google Scholar
• Brennan FH, Gordon R, Lao HW, Biggins PJ, Taylor SM, Franklin RJ, Woodruff TM, Ruitenberg MJ. The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury. J Neurosci. 2015;35(16):6517–6531. doi:10.1523/JNEUROSCI.5218-14.2015.
   PubMed Web of Science ®Google Scholar
• Lim J, Iyer A, Suen JY, Seow V, Reid RC, Brown L, Fairlie DP. C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 2013;27(2):822–831. doi:10.1096/fj.12-220582.
   PubMed Web of Science ®Google Scholar
• Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, Coukos G, Lambris JD. Modulation of the antitumor immune response by complement. Nat Immunol. 2008;9(11):1225–1235. doi:10.1038/ni.1655.
   PubMed Web of Science ®Google Scholar
• Calleja-Conde J, Echeverry-Alzate V, Bühler K-M, Durán-González P, Morales-García JÁ, Segovia-Rodríguez L, Rodríguez de Fonseca F, Giné E, López-Moreno J. The immune System through the Lens of alcohol intake and gut microbiota. Int J Mol Sci. 2021;22(14):7485. doi:10.3390/ijms22147485.
   PubMed Web of Science ®Google Scholar
• Meadows GG, Blank SE, Duncan DD. Influence of ethanol consumption on natural killer cell activity in mice. Alcohol Clin Exp Res. 1989;13(4):476–479. doi:10.1111/j.1530-0277.1989.tb00359.x.
   PubMed Web of Science ®Google Scholar
• Cui K, Yan G, Zheng X, Bai L, Wei H, Sun R, Tian Z. Suppression of natural killer cell activity by regulatory NKT10 cells aggravates alcoholic hepatosteatosis. Front Immunol. 2017;8:1414. doi:10.3389/fimmu.2017.01414.
   PubMed Web of Science ®Google Scholar
• Zhang F, Little A, Zhang H. Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15. J Leukoc Biol. 2017;101(4):1015–1027. doi:10.1189/jlb.1A0716-298RR.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Schwarz M, Delzenne NM, Starkel P, de Timary P. Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms. Transl Psychiatry. 2021;11(1):503. doi:10.1038/s41398-021-01610-5.
   PubMed Web of Science ®Google Scholar
• Seo B, Jeon K, Moon S, Lee K, Kim WK, Jeong H, Cha KH, Lim MY, Kang W, Kweon M-N, et al. Roseburia spp. Abundance Associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice. Cell Host & Microbe. 2020;27(1):25–40.e6. doi:10.1016/j.chom.2019.11.001.
   PubMed Web of Science ®Google Scholar
• Smirnova E, Puri P, Muthiah MD, Daitya K, Brown R, Chalasani N, Liangpunsakul S, Shah VH, Gelow K, Siddiqui MS, et al. Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity. Hepatology. 2020;72(1):271–286. doi:10.1002/hep.31178.
   PubMed Web of Science ®Google Scholar
• Lang S, Fairfied B, Gao B, Duan Y, Zhang X, Fouts DE, Schnabl B. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients. Gut Microbes. 2020;12(1):1785251. doi:10.1080/19490976.2020.1785251.
   PubMed Web of Science ®Google Scholar
• Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes. 2021;13(1):1848158. doi:10.1080/19490976.2020.1848158.
   PubMed Web of Science ®Google Scholar
• Zheng T-X, Pu S-L, Tan P, Du Y-C, Qian B-L, Chen H, Fu W-G, Huang M-Z. Liver metabolomics reveals the effect of lactobacillus reuteri on alcoholic liver disease. Front Physiol. 2020;11:595382. doi:10.3389/fphys.2020.595382.
   PubMed Web of Science ®Google Scholar
• Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol: WJG. 2010;16(11):1321. doi:10.3748/wjg.v16.i11.1321.
   PubMed Web of Science ®Google Scholar
• Poritz LS, Harris LR 3rd, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci. 2011;56(10):2802–2809. doi:10.1007/s10620-011-1688-9.
   PubMed Web of Science ®Google Scholar
• Zuluaga P, Teniente-Serra A, Fuster D, Quirant-Sanchez B, Hernandez-Rubio A, Martinez-Caceres E, Muga R. Increased natural killer cells are associated with alcohol liver fibrosis and with T cell and cytotoxic subpopulations change. J Clin Med. 2022;11(2):11. doi:10.3390/jcm11020305.
   Web of Science ®Google Scholar
• Lee MJ, Blish CA. Defining the role of natural killer cells in COVID-19. Nat Immunol. 2023;24(10):1628–1638. doi:10.1038/s41590-023-01560-8.
   PubMed Web of Science ®Google Scholar
• Molteni M, Gemma S, Rossetti C. The role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm. 2016;2016:6978936. doi:10.1155/2016/6978936.
   PubMed Web of Science ®Google Scholar
• Ding P, Li L, Li L, Lv X, Zhou D, Wang Q, Chen J, Yang C, Xu E, Dai W, et al. C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation. Theranostics. 2020;10(19):8619. doi:10.7150/thno.45058.
   PubMed Web of Science ®Google Scholar